Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
$0.10
$0.11
$0.06
$0.18
$214.01M1.54369,523 shs304,794 shs
Myomo, Inc. stock logo
MYO
Myomo
$1.08
+3.8%
$1.13
$0.61
$2.02
$40.18M1.5322,549 shs311,777 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
+2.70%+5.56%-17.61%-22.39%-30.56%
Myomo, Inc. stock logo
MYO
Myomo
+2.97%-1.89%+0.97%+18.53%-44.39%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
$0.10
$0.11
$0.06
$0.18
$214.01M1.54369,523 shs304,794 shs
Myomo, Inc. stock logo
MYO
Myomo
$1.08
+3.8%
$1.13
$0.61
$2.02
$40.18M1.5322,549 shs311,777 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
+2.70%+5.56%-17.61%-22.39%-30.56%
Myomo, Inc. stock logo
MYO
Myomo
+2.97%-1.89%+0.97%+18.53%-44.39%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
0.00
N/AN/AN/A
Myomo, Inc. stock logo
MYO
Myomo
3.00
Buy$7.50594.44% Upside

Current Analyst Ratings Breakdown

Latest BRCHF and MYO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/8/2026
Myomo, Inc. stock logo
MYO
Myomo
Boost Price TargetBuy$9.50 ➝ $10.00
(Data available from 8/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
$400K535.03N/AN/AN/A
Myomo, Inc. stock logo
MYO
Myomo
$40.93M1.02N/AN/A$0.30 per share3.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
N/AN/AN/AN/AN/AN/AN/AN/A8/21/2026 (Estimated)
Myomo, Inc. stock logo
MYO
Myomo
-$15.57M-$0.23N/AN/AN/A-36.69%-119.60%-42.50%8/5/2026 (Confirmed)

Latest BRCHF and MYO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2026Q2 2026
Myomo, Inc. stock logo
MYO
Myomo
-$0.10N/AN/AN/A$10.35 millionN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
N/AN/AN/AN/AN/A
Myomo, Inc. stock logo
MYO
Myomo
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
N/AN/AN/A
Myomo, Inc. stock logo
MYO
Myomo
1.21
2.73
2.36

Institutional Ownership

CompanyInstitutional Ownership
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
N/A
Myomo, Inc. stock logo
MYO
Myomo
44.99%

Insider Ownership

CompanyInsider Ownership
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
N/A
Myomo, Inc. stock logo
MYO
Myomo
12.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
Brainchip Holdings Ltd. stock logo
BRCHF
Brainchip
782.25 billionN/ANot Optionable
Myomo, Inc. stock logo
MYO
Myomo
9038.64 million33.95 millionNot Optionable

Recent News About These Companies

Myomo (MYO) Projected to Announce Quarterly Earnings on Wednesday
Myomo Inc.
Myomo Inc Stock Guidance
Myomo, Inc. Q1 2026 Earnings Call Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

Brainchip stock logo

Brainchip OTCMKTS:BRCHF

$0.10 0.00 (0.00%)
As of 05:28 PM Eastern

BrainChip Holdings Ltd develops software and hardware accelerated solutions for artificial intelligence and machine learning applications in North America, Oceania, Europe, the Middle East, and Asia. The company primarily focuses on development of Akida Neuromorphic Processor to provide ultra-low power and fast AI Edge Network for vision, audio, olfactory, and smart transducer applications. It also offers Akida IP, a neural processor; MetaTF, which is used for creation, training, and testing of neutral network; Akida enablement platforms, including Akida PCI, Edge AI box, and development kit and shuttle PC and raspberry Pi; AKD1000, a reference chip as a hardware accelerator; and 2nd generation akidaTM expands the benefits of event-based, neuromorphic processing for network models. In addition, the company provides MetaTF ML framework python packages, which includes Akida python package, an interface to the BrainChip Akida Neuromorphic System-on-Chip; CNN2SNN tool provides means to convert convolutional neural networks; and the Akida model zoo, a pre-created network models built with the Akida sequential API and the CNN2SNN tool using quantized Keras models. Its products are used for original equipment manufacturer, end users, and system integrators based on artificial neural networks. The company was formerly known as Aziana Limited. BrainChip Holdings Ltd was incorporated in 2011 and is based in Sydney, Australia.

Myomo stock logo

Myomo NYSEAMERICAN:MYO

$1.08 +0.04 (+3.85%)
Closing price 04:10 PM Eastern
Extended Trading
$1.09 +0.01 (+0.83%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.